CJC-1295 w/DAC

CJC-1295 (with DAC) – Research Compound (5 mg)

CJC-1295 with DAC is a synthetic growth hormone–releasing hormone (GHRH) analog supplied as a lyophilized peptide for scientific research involving endocrine signaling pathways and peptide–receptor interactions. The DAC (Drug Affinity Complex) modification is designed to extend peptide stability in experimental models, making it suitable for laboratory investigations of prolonged signaling mechanisms.

This product is manufactured and distributed strictly for controlled in vitro research applications.

Product Specifications

• Quantity: 5 mg per vial

• Form: Lyophilized powder

• Appearance: White to off-white solid

• Molecular Weight: ~3647.85 Da

• Storage (unreconstituted): Store refrigerated at 2°C–8°C in a dry, dark location

• Storage (reconstituted): Refrigerate at 2°C–8°C

Research Use Only

This product is intended exclusively for laboratory research purposes. It is not intended for human or animal consumption, clinical use, diagnostic procedures, therapeutic applications, dietary use, cosmetic use, or veterinary use.

This product has not been evaluated or approved by the FDA or any other regulatory authority.

Disclaimer

All information provided is for educational and research reference purposes only. No claims are made regarding safety, efficacy, or suitability for any specific application. The purchaser assumes full responsibility for proper handling, storage, use, and disposal in compliance with all applicable local, state, and federal regulations.